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Background: There are major concerns over sustaining the efficacy of current malaria vector control interventions
given the rapid spread of resistance, particularly to pyrethroids. This study assessed the bioefficacy of five WHO-
recommended long-lasting insecticidal nets (LLINs) against pyrethroid-resistant Anopheles gambiae field populations
from Uganda.
Methods: Adult An. gambiae from Lira, Tororo, Wakiso and Kanungu districts were exposed to permethrin (0.75%)
or deltamethrin (0.05%) in standard WHO susceptibility tests. Cone bioassays were used to measure the bioefficacy
of four mono-treated LLINs (Olyset®, Interceptor®, Netprotect® and PermaNet® 2.0) and one combination LLIN
(PermaNet® 3.0) against the four mosquito populations. Wireball assays were similarly conducted to determine
knockdown rates. Species composition and kdr mutation frequency were determined for a sample of mosquitoes
from each population. Chemical assays confirmed that test nets fell within target dose ranges.
Results: Anopheles gambiae s.s. predominated at all four sites (86 - 99% of Anopheles spp.) with moderate kdr
L1014S allelic frequency (0.34 – 0.37). Confirmed or possible resistance to both permethrin and deltamethrin was
identified for all four test populations. Reduced susceptibility to standard LLINs was observed for all four
populations, with mortality rates as low as 45.8% even though the nets were unused. The combination LLIN
PermaNet®3.0 showed the highest overall bioefficacy against all four An. gambiae s.l. populations (98.5 - 100%
mortality). Wireball assays provided a more sensitive indicator of comparative bioefficacy, and PermaNet 3.0 was
again associated with the highest bioefficacy against all four populations (76.5 – 91.7% mortality after 30 mins).
Conclusions: The bioefficacy of mono-treated LLINs against pyrethroid-resistant field populations of An. gambiae
varied by LLIN type and mosquito population, indicating that certain LLINs may be more suitable than others at
particular sites. In contrast, the combination LLIN PermaNet 3.0 performed optimally against the four An. gambiae
populations tested. The observed reduced susceptibility of malaria vectors to mono-treated LLINs is of particular
concern, especially considering all nets were unused. With ongoing scale-up of insecticidal tools in the advent of
increasing resistance, it is essential that those interventions with proven enhanced efficacy are given preference
particularly in areas with high resistance.
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Figure 1 Map of Uganda showing the origin of the four An.
gambiae s.l. populations used in WHO susceptibility tests,
species and resistance mechanisms investigations and
LLIN bioassays.
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Malaria remains a major public health problem, causing
an estimated 225 million disease cases and 781,000
deaths per year, especially among children aged less than
five years [1]. The disease is transmitted by anopheline
mosquitoes and vector control is one of the most im-
portant means of malaria prevention. There is evidence
that the use of insecticide-treated nets (ITNs) on a large
scale decreases malaria related morbidity and mortality
[2,3] and for this reason, the use of ITNs has been con-
sidered an important tool in the Roll Back Malaria
(RBM) strategy.
Unlike conventional ITNs which lose effective insecti-
cide after one or two washes and maintain bioefficacy
for a maximum of 6–12 months, long-lasting insecticidal
nets (LLINs) in which insecticide is either incorporated
into the fibre during extrusion or coated on the fibre fol-
lowing extrusion, retain effectiveness against susceptible
Anopheles spp. vectors for up to 20 standard WHO la-
boratory washes and 3 years of recommended usage
under field conditions [4]. All LLINs are currently
treated with pyrethroids due to their relative safety for
humans at low dosage, repellent properties, rapid knock-
down rates and killing effects [5]. However, pyrethroid
resistance in mosquito vectors as reported in many Afri-
can countries [6] could limit the efficacy of LLINs as
shown by findings of decreased efficacy of LLINs in
Benin, Mali and Zanzibar [7-9].
Insecticide resistance is mediated either by mutations
in the target site of the insecticide or its active metabo-
lites (target site resistance), through enzymatic modifica-
tion of insecticides to produce non-toxic metabolites
(metabolic detoxification), via behaviour resistance or
through reduced penetration of the insecticide into the
vector species [10]. Several factors can select for resist-
ance in mosquito vector species, such as overuse of in-
secticide, whether in ITNs, indoor residual spraying
(IRS) or through agricultural applications which account
for huge insecticide inputs of almost all available classes
of insecticides [11,12]. In Uganda, there is widespread
insecticide resistance in the main malaria vector species,
An. gambiae s.s, An. arabiensis and An. funestus [13-18].
This resistance is due to both target site (kdr) and meta-
bolic mechanisms and there is cross-resistance between
DDT and pyrethroids. There are currently no reports of
organophosphate resistance but resistance to carbamates
including propoxur has been reported [13-18].
The current strategy of the National Malaria Control
Programme (NMCP) in Uganda is based on effective
case management and vector control using LLINs and
IRS. Insecticide resistance monitoring is therefore essen-
tial to guide implementation of more effective and sus-
tainable vector control. There have been limited data on
comparative efficacy of World Health Organization(WHO)-recommended LLINs against field-derived pop-
ulations of Anopheles spp. from different transmission
zones within single countries. Rather, efficacy has largely
been measured in specific areas via experimental huts
with only one or two nets assessed in relation to con-
trols. In Uganda, one study showed progressive reduc-
tions over a 10 year period in susceptibility of An.
funestus from the western region to nets treated with
three different insecticides. However, non-standard bio-
assay techniques were used and mosquitoes from five
parishes were pooled for assessments [15]. In the ab-
sence of experimental huts and in order to assess sus-
ceptibility to LLINs of multiple local malaria vector
species, the Uganda NMCP initiated the present study
using WHO-recommended LLINs against local Anoph-
eles gambiae populations. Outcomes are expected to be
applied in evidence-based decision making on the most
appropriate LLINs for application in malaria prevention
and control in specific regions of the country.
Methods
Mosquito collections
Collections were conducted in April and October 2011
in the districts of Lira, Tororo, Wakiso and Kanungu lo-
cated in Northern, Eastern, Central and Western regions
of Uganda, respectively (Figure 1). In these four districts,
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Tororo) to medium-high (Wakiso) to low (Kanungu)
(Additional file 1). Previous studies identified the pres-
ence of kdr mutations in An. gambiae s.l. from Tororo
district in the eastern part of the country, Apac district
in northern Uganda near the current study district of
Lira, in the central part of the country and in Kyenjojo
and Kanungu in the western part of the country, with
kdr frequencies ranging from 25% to 30% in these dis-
tricts [14,16-19]. Metabolic resistance mechanisms have
also been implicated in populations from Tororo with a
significant increase in esterase activity detected [17].
Female Anopheles spp. adult mosquitoes were col-
lected via standard resting catches from houses and lar-
vae were collected from breeding sites within the study
districts, and all were transported to the Vector Control
Division (VCD) insectary in Kampala. Blood-fed and
gravid females were allowed to oviposit, eggs were
hatched and larvae were pooled for each collection dis-
trict. Field-collected larvae were also pooled by collec-
tion district. All preimaginal stages were reared to adults
under conditions of ambient temperature and humidity
with 12:12 hours of light: dark cycle. Unfed adult fe-
males at 2 – 5 days post-emergence were identified mor-
phologically as previously described [20] at the Centre
for Research on Infectious Diseases Laboratory, College
of Health Science Makerere University, Kampala. Only
An. gambiae s.l. mosquitoes were used in WHO suscep-
tibility tests and cone bioassays.
Insecticide susceptibility and molecular testing
Standard WHO susceptibility tests were conducted to
determine mortality rates (MT) following one hour of
exposure to papers treated with either permethrin
(0.75%) or deltamethrin (0.05%). Concurrent negative
controls were run using untreated papers. Test popula-
tions were classified as susceptible (≥98% MT), possibly
resistant (80-97%) or confirmed resistant (<80% MT)
[21]. Mosquitoes used in controls were stored in contact
with silica gel desiccant. A random sample of 100 mos-
quitoes from each site was used in species identification
by restriction fragment length polymerase chain reaction
[22] and determination of kdr mutation frequency by
allele-specific polymerase chain reaction [23,24]. All
PCR runs for kdr analyses included controls of wild type
homozygote, heterozygote and kdr homozygote mosqui-
toes for both L1014S and L1014F.
LLIN samples
All LLINs as well as the untreated control nets were
obtained from the local market. All had an unknown
storage history but were within the specified pro-
duct shelf-life. LLINs included in the study were: Olyset®
Net (polyethylene with permethrin incorporated at 20 g/kg ± 3 g/kg), Interceptor® (polyester coated with
alphacypermethrin at 200 mg/m2 ± 25%), NetProtect®
(polyethylene with deltamethrin incorporated at 1.8 g/
kg ± 25%), PermaNet® 2.0 (polyester coated with
deltamethrin at 55 mg/m2 ± 25%) and PermaNet® 3.0
(polyethylene roof with deltamethrin incorporated at 2.8
g/kg ± 25% and piperonyl butoxide (PBO) incorporated at
4.0 g/kg ± 25% in the roof and sides coated with
deltamethrin at 2.8 g/kg ± 25%). PBO is a synergist that in-
creases the rate of penetration of insecticide into the in-
sect [25] and inhibits the metabolic enzymes the mosquito
uses to sequester or break-down the insecticide [26].
All LLINs were rectangular with sub-samples of 30 ×
30 cm taken from the roof section (2 per net) and side
sections (1 each from the upper and lower part of the
two long sides of each net) to give a total of 6 sub-
samples for each net for use in bioassays. Four nets of
each type were used for a total of 24 sub-samples of each
net type assessed via cone bioassays. Identical sub-
sampling was performed in adjacent areas for reference
samples used in chemical assays. All samples were rolled
up and placed individually in a labelled clean aluminium
foil prior to assays.
LLIN chemical analyses
Assays were conducted via high performance liquid
chromatography (HPLC) to confirm whether chemical
concentrations were within product specifications for
each individual LLIN. Analyses were conducted at an
ISO IEC 17025-accredited laboratory. Deltamethrin was
assessed by normal-phase HPLC according to CIP333/
LN. Alpha-cypermethrin was extracted with n-hexane
and 1, 4-dioxane (95:5 v/v) with the mixture then shaken
and sonicated and filtered on a 0.45 mm teflon mem-
brane, whereas for permethrin and PBO, hot xylene ex-
traction was followed by drying, reconstitution and
filtration after which both were assessed via HPLC.
LLIN bioassays
Standard WHO cone bioassays [4] were used to deter-
mine bioefficacy of LLINs against field-derived popula-
tions as well as against a susceptible laboratory-reared
Anopheles gambiae s.s. strain (Kisumu). The Kisumu col-
ony was established at the Vector Control Division
(VCD) of the Ministry of Health in Kampala in 2011,
with full susceptibility (100% mortality) to permethrin
(0.75%) and deltamethrin (0.05%) confirmed via standard
WHO susceptibility tests prior to assays. At the VCD in-
sectary, five non-blood fed 2-to 5-day old Anopheles fe-
males were exposed to each sub-sample for 3 minutes,
removed and kept in holding containers with access to
sugar solution. Knockdown (KD) was recorded at 60 mi-
nutes post-exposure and mortality (MT) was recorded
after 24 hours. Two cone tests were conducted per sub-
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laboratory susceptible population such that 240 mos-
quito of each of the five populations were tested for each
net type. Mosquitoes exposed to untreated nets were
used as controls with all concurrent results discarded if
MT was ≥20% and Abbott’s adjustment applied if MT
was >5% for the controls.
Wireball assays were used to measure knockdown fol-
lowing 30 and 60 mins of continuous exposure to an
LLIN in a wireball. This approach was included as it is
of use where mortality rates may be lower and hence
longer exposure times are required, or where high repel-
lency of the insecticide may compel mosquitoes to rest
on the cone interior rather than on the LLIN. Net sub-
samples were wrapped around a wire frame of three
intersecting circles of 15 cm in diameter with the netting
secured around the frame in such a way that a “sleeve”
was left through which 11 mosquitoes were introduced.
Numbers of mosquitoes knocked down after 30 mins
(KD30) and 60 mins (KD60) were recorded. Mosquitoes
were then transferred to holding cups for 24-hour post-
exposure readings. For each individual sub-sample, four
wire-ball tests were conducted such that 44 mosquitoes
were tested per sub-sample. With 3 sub-samples of each
individual net and 3 nets of each type, a total of 396
mosquitoes were tested for each net type. Controls were
run concurrently with interpretation as for cone
bioassays.
Data analyses
For cone bioassays, KD and MT were compared for in-
dividual samples via regression analyses. Data, aggre-
gated for mosquito population, net type and net section,
were assessed via ANOVA with Duncan’s multiple com-
parison procedure. Data were then combined for net
sections and assays were repeated. Wireball assay data
for KD30 and KD60 were similarly analyzed.
Results
Population characterisation and insecticide susceptibility
For the population analyses, the majority of collected fe-
males were morphologically identified as An. gambiae
s.l. (391/400) with a small proportion identified as An.
funestus s.l. (9/400). Molecular analyses indicated that at




Identified (no.) An. funestus (%) An. arabiensis (%)
Kanungu 98 2.0 0.0
Lira 100 0.0 1.0
Tororo 99 1.0 13.1
Wakiso 100 6.0 0.0The kdr mutation L1014S was detected in 257 of the
363 An. gambiae s.s. successfully tested, with overall
29.2% homozygous wild type (SS), 70.5% heterozygous
(RS) and one single homozygous resistant (RR) mosquito
detected from Kanungu. The kdr allelic frequency was
moderate at all sites, and varied from 0.34 at Lira to 0.37
at Wakiso. Genotype frequencies for all populations did
not adhere to Hardy-Weinberg expectations. All An.
arabiensis tested (14) were wild type. No L1014F muta-
tions were observed in any species.
Only An. gambiae s.l. were used in further assays.
WHO susceptibility tests confirmed resistance to both
permethrin and deltamethrin for the populations from
Lira and Tororo (Table 2). There was confirmed resist-
ance to permethrin and possible resistance to
deltamethrin for the population from Kanungu, and pos-
sible resistance to both pyrethroids for the population
from Wakiso. At all the four sites, higher resistance to
permethrin was identified than to deltamethrin at the
standard tested dosages. The Kisumu laboratory strain
of An. gambiae s.s. was 100% susceptible to both
pyrethroids.
LLINs and bioassays
All LLIN sub-samples had optimal bioefficacy (100% KD
and 100% MT), against the susceptible An. gambiae s.s.
(Kisumu), strain in cone bioassays, with the exception of
Interceptor (78.8% and 80.0% KD for upper and lower
sides respectively, and 97.5% MT for upper side) and
Olyset (92.5% KD for upper side). For wireball assays
with the susceptible strain, KD30 ranged between 84.8
and 93.3% with 100% MT at 24 hours post-exposure for
all LLINs. Chemical analyses confirmed that all LLINs
exceeded the specified lower cut-off level for insecticide
(or synergist) concentration though there were two in-
stances where LLIN sub-samples slightly exceeded the
upper limits i.e., roof of PermaNet 2.0 and sides of Inter-
ceptor (Table 3).
An overall association was identified between KD and
MT for cone bioassays on individual sub-samples
(n = 720; R2 = 0.8903; P <0.0001), while associations on
aggregated data showed correlation between KD and
MT for Interceptor against all four mosquito popula-
tions, Olyset for 3 populations, and for the remaining
LLINs two populations only (P < 0.05 for all specified).ion frequency in An. gambiae s.s.from the four study sites
An. gambiae s.s.kdrmutation





Table 2 Susceptibility to permethrin and deltamethrin of An. gambiae adult female mosquitoes collected from four
sites in Uganda and the laboratory An. gambiae s.s. (Kisumu) strain determined via standard WHO susceptibility tests















Kanungu 100 68 Confirmed resistant 100 97 Possibly resistant
Lira 100 60 Confirmed resistant 100 71 Confirmed resistant
Tororo 100 53 Confirmed resistant 100 66 Confirmed resistant
Wakiso 100 90 Possibly resistant 100 94 Possibly resistant
Kisumu 100 100 Susceptible 100 100 Susceptible
^ Susceptible (≥98%), possibly resistant (80–97), confirmed resistant (<80%).
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upper sides, lower sides) indicated no difference among
net types with the exception of Olyset against both the
Kanungu and Tororo strains for both KD and MT
(P < 0.05). Thus, there was no significant difference ob-
served in the deltamethrin plus PBO roof and the
deltamethrin-only sides of PermaNet 3.0, presumably be-
cause bioefficacy of the three sections was high against
all four populations (≥87.9% KD and ≥ 97.5% MT). As
such, data were aggregated by net type for subsequent
analyses with data presented for MT.
Reduced susceptibility to LLINs was observed for all
four field populations of An. gambiae. Bioefficacy varied
between LLINs in cone bioassays with each of the four
populations for both KD (P < 0.001 for all) and MT (P <
0.001 for all). Mean MT differed by 46.7% (range: 53.3-
100%) for the Kanungu population, 54.2% (range: 45.8-
100%) for the Lira population, 35.0% (range: 63.5-98.5%)
for the Tororo population and 40.0% (range: 60.0-100)
for the Wakiso population (Figure 2). PermaNet 3.0
exhibited the highest bioefficacy against all the four pop-
ulations (98.5 – 100%). When data were analyzed via
multiple comparison methods, PermaNet 3.0 performed
significantly better than the mono-treated LLINs at Lira
and Wakiso, and equal best with NetProtect at Kanungu
and Olyset at Tororo. Each of the mono-treated LLINsTable 3 Target concentration and range and mean insecticida
performance liquid chromatography for roof and side sub-sa
evaluations
Target conc
Net type Chemical Units Mean
PermaNet 3.0 Deltamethrin g/kg 2.8 (side
g/kg 4 (roof)
Piperonyl butoxide g/kg 25 (roof
PermaNet 2.0 Deltamethrin mg/m2 55
NetProtect Deltamethrin g/kg 1.8
Interceptor Alpha-cypermethrin mg/m2 200
Olyset Permethrin g/kg 20also varied in bioefficacy for the four different popula-
tions for both KD (P < 0.001) and MT (P < 0.001). For
PermaNet 3.0, there was no identifiable difference in
bioefficacy against the four populations for either KD
(P = 0.1011) or MT (P = 0.0890), presumably because
bioefficacy was high against all populations. Conversely,
there was also no significant difference in bioefficacy of
the untreated net between populations since KD and
MT were minimal for all.
Wireball assays also indicated differences in LLIN
bioefficacy between net types for each of the four field
populations, with PermaNet 3.0 resulting in the highest
KD30 against all populations (76.5 – 91.7%) (Table 4).
Bioefficacy also varied against the susceptible An.
gambiae s.s. (Kisumu) strain (P < 0.001) and was highest
for PermaNet 3.0 followed by PermaNet 2.0 and then
the other LLINs, indicating that KD30 from wireball as-
says may be a more sensitive indicator of bioefficacy
than KD and MT from cone bioassays. Bioefficacy of
specific net types also varied against the different
populations for the mono-treated LLINs (P < 0.001) and
in contrast to the cone bioassay data, also varied ac-
ross populations for PermaNet 3.0 (P = 0.0063) with the
lowest KD30 (76.5%) observed against the Kanungu
population. There was a significant overall association
between KD30 and KD60 (n = 348; R
2 = 0.8844;l or synergist concentration measured via high
mples of five different LLIN types used in bioefficacy
entration Mean measured concentration
Range Roof Sides
s) 2.1 - 3.5 - 3.1
3.0 - 5.0 3.9 -
) 18.8 - 31.3 18.7 -
41.3 - 68.8 69.4 65.6
1.4 - 2.3 1.6 1.6
150.0 - 250.0 171.0 251.0
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KANUNGU LIRA
WAKISOTORORO
Figure 2 Bioefficacy (mean % 24-hour mortality) in cone bioassays of WHO-recommended LLINs against field-derived An. gambiae
populations from four sites in Uganda. Vertical lines indicate standard error (n = 24). The same letter and shading within graphs indicates no
significant difference (via Duncan’s multiple comparison procedure at P < 0.05).
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only for PermaNet 3.0 against the Kanungu population
(P = 0.0160) and Olyset against the Lira population
(P = 0.0240).
There was some concurrence between cone bioassays
and wireball assays, especially for PermaNet 3.0, which
exhibited high bioefficacy in both assay types (Figure 3).
Considering both assay types, PermaNet 3.0 per-
formed best or equal best against all four populations.
NetProtect also performed well in cone bioassays againstTable 4 Bioefficacy in wireball assays (mean % 30-minute kno
derived An. gambiae populations from four sites in Uganda a
(Kisumu)
Mosquito population Olyset Interceptor NetProtect P
Kanungu 42.4C 45.5C 47.7C
Lira 67.4C 76.5B,C 83.3A,B
Tororo 76.5A,B 76.5A,B 83.3A
Wakiso 75.8B 41.7D 65.9C
Kisumu 84.9B 86.4B 84.9B
Same letter in rows indicates no significant difference (via Duncan’s multiple compa
nt: not tested due to limited numbers of mosquitoes available.the Kanungu population and in wireball assays against
the Lira population. Olyset performed well in cone bio-
assays against the Tororo population and three mono-
treated LLINs also performed well in wireball assays
against this population, indicating that the Tororo popu-
lation was overall the most susceptible to LLINs. In gen-
eral, cone bioassays indicated that LLINs had the lowest
efficacy against the Lira and Wakiso populations (72.3
and 74.2% MT, respectively), but wireball assays indi-
cated the lowest efficacy against the Kanungu populationckdown) of WHO-recommended LLINs against field-
nd a susceptible laboratory An. gambiae s.s. strain
Net type P-
valueermaNet 2.0 PermaNet 3.0 Untreated control
63.6B 76.5A 0.0D <0.0001
70.5C 86.4A 0.0D <0.0001
70.5B 86.4A nt 0.0241
81.8B 91.7A 0.0E <0.0001
90.2A,B 93.3A 0.0C <0.0001





























Figure 3 Comparative bioefficacy of different LLIN types as determined via wireball versus cone bioassays for four populations of An.
gambiae from Uganda.
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population for both bioassays.
Discussion
This is the first study to compare the response of field
populations of malaria vectors from multiple sites in
Uganda to WHOPES-recommended LLINs. Wide varia-
tions were observed in susceptibility to the different net
types even within specific mosquito populations, with re-
duced susceptibility to pyrethroid-only LLINs observed
for all four populations. Cone bioassays indicated that for
two populations, a single mono-treated LLIN performed
well (i.e., NetProtect at Kanungu and Olyset at Tororo),
while optimal efficacy of the combination LLIN PermaNet
3.0 was observed for all four populations. Bioefficacy of
LLINs differed by almost 50% against some populations
(e.g. Kanungu had 53.3% MT with Interceptor and 100%
MT with PermaNet 3.0 in cone bioassays).
Yewhalaw and colleagues [27] similarly observed re-
duction in the bioefficacy of standard LLINs against
four pyrethroid-resistant An. arabiensis populations
from the Jimma region of Ethiopia. In contrast to re-
sults herein, the PBO plus deltamethrin roof had
higher bioefficacy than the pyrethroid-only sides of
PermaNet 3.0. While the Ethiopia data provide evi-
dence to indicate that PBO was effectively restoring
susceptibility of the An. arabiensis populations to
deltamethrin, this could not be demonstrated in the
current investigation since bioefficacy of the
deltamethrin-only sides of PermaNet 3.0 was optimal
against the Uganda An. gambiae populations. Studies
comparing the bioefficacy of PermaNet 3.0 versus
deltamethrin- or permethrin-only LLINs in experimen-
tal huts have been conducted in numerous countrieswith results indicating that comparative bioefficacy will
largely depend on the levels and types of resistance
mechanisms present in the local vector species [28-32].
Data from some of these studies were applied in a
malaria transmission model to compare PermaNet 3.0
to the deltamethrin-only PermaNet 2.0 under condi-
tions of high net coverage (80%), with outputs indicat-
ing that PermaNet 3.0 (new and washed 20 times) had
consistently higher impact on entomological inocula-
tions rates across four sites with pyrethroid resistant
Anopheles spp. [33].
Observed variation in susceptibility of Anopheles pop-
ulations to pyrethroid-only LLINs indicates that particu-
lar LLINs may be more suitable for deployment in
specific regions. This is due to anticipated differences in
bioefficacy depending on characteristics of individual
mosquito populations. This is currently seldom a consid-
eration in selection of LLINs for wide-scale deployment,
which is usually guided by availability, price and other
factors such as user acceptability of the polymer type
(e.g. polyester versus polyethylene). Reliance on pheno-
typic susceptibility status to select nets by active ingredi-
ent is also not appropriate since results from WHO
susceptibility tests cannot be extrapolated to expected
results from LLIN bioassays. In this study, susceptibility
to the permethrin LLINs was highest for the population
found to be least susceptible to permethrin (Tororo).
Comparative bioefficacy evaluations using local vector
populations such as presented in this study provide valu-
able data to inform selection of appropriate interven-
tions. The consistently optimal bioefficacy of PermaNet
3.0 indicates that this combination LLIN represents a
viable option for areas with pyrethroid-resistant Anoph-
eles spp.
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dence of increasing pyrethroid resistance in Uganda,
which is consistent with observations from other studies
[13-19]. The kdr mutation (L1014S) was detected at a
moderate frequency (34–37%) in An. gambiae s.s. across
all four sites. Although metabolic resistance assays were
not conducted, it is likely that these kdr mutations may
in part be contributing to the observed reductions in ef-
ficacy of the standard LLINs. In another study in se-
lected areas in Uganda with resistant vector populations,
kdr frequency was found to be notably higher in P. fal-
ciparum-infected mosquitoes, which contributed to 70%
of the malaria transmission during the dry season [18].
Although fitness cost was not assessed, this potential for
higher infectivity may have enormous implications for
malaria transmission and might jeopardize current re-
sistance management strategies. It also indicates that
such resistance may be affecting the bioefficacy of
insecticide-based vector control interventions, such as
LLINs. This requires confirmation, using standard WHO
approaches such as Phase II experimental hut trials or
robust longitudinal and multi-site village trials since the
observations in this study were based only on cone and
wireball bioassays conducted under laboratory condi-
tions. However, the low KD and MT rates observed give
some indication that there may be reductions in the abil-
ity of mono-treated LLINs to kill mosquitoes under field
conditions [34], and that their continued use may have
limited impact on malaria prevention and control in
Uganda. Reductions in efficacy of insecticidal interven-
tions ,due to resistance, has been noted elsewhere, such
as in South Africa, Benin, Mali and Equatorial Guinea
[7,8,35,36]. Accordingly, further investigations in Uganda
are warranted.
The reduced susceptibility to permethrin and
deltamethrin observed for the four field populations of
An. gambiae s.l. was similarly noted in assessments
conducted between 2004 to 2006 and in 2009 and 2011
in Central and Eastern Uganda, with kdr identified as
the main resistance mechanism and metabolic resistance
also implicated for Tororo district [18]. In the current
study, resistance was higher in Tororo, Kanungu and
Lira than in Wakiso districts perhaps due to the histor-
ical widespread use of insecticides such as organochlo-
rines and pyrethroids in the cotton growing districts of
Tororo and Lira and in the tea cultivation fields of
Kanungu. Resistance may also have arisen from selective
pressure exerted due to the rapid scale-up of malaria in-
terventions, such as LLINs and IRS. The fact that the
kdr mutational assortments in the four tested popula-
tions did not meet Hardy-Weinberg expectations is a
further indication that the populations are likely cur-
rently undergoing selective pressure. Interestingly, the
frequency of L1014S in the An. gambiae s.s. from Tororoin this study (35%), was significantly lower than that
reported in 2008 (86%), but was more similar to earlier
reports from 2006 (47%) and 2002 (29%) [16,18]. While
rapid geographical spread of insecticide resistance alleles
has been noted from ongoing longitudinal studies [37],
evidence of such rapid reversion to wild type is limited
and thus this warrants further investigation. The pres-
ence of multiple resistance mechanisms in malaria vec-
tor species in Tororo may have severe implications for
control efforts and further testing for metabolic resist-
ance mechanisms in Uganda should be prioritized.
The WHO recommends that action against insecticide
resistance should be immediate and pre-emptive, not re-
sponsive [37]. Data as presented here provides evidence
for guiding decisions on the selection of LLINs with the
highest efficacy for use in specific regions of Uganda.
Evidence-based decision making was successfully applied
by the Uganda National Malaria Control Programme in
2009 when there was a switch from the use of pyre-
throids to carbamates for IRS, following results from re-
sistance studies indicating reduced susceptibility to
pyrethoids in major malaria vectors (Additional files 2
and 3) in Northern Uganda. More comprehensive stud-
ies will be needed to ascertain the bioefficacy of LLINs
in Uganda, although the WHO cautions against awaiting
indisputable proof of control failures before taking ac-
tion against insecticide resistance [37]. With the new
global initiative of the Roll Back Malaria (RBM) partner-
ship to scale up for impact (SUFI), PermaNet 3.0 may be
the most appropriate LLINs to use for malaria preven-
tion particularly in the Northern and Central regions of
Uganda where pyrethroid-resistance is already high and
there is proof of increased bioefficacy relative to stand-
ard LLINs. Despite concerted efforts by the Ministry of
Health to control malaria in Lira and neighbouring dis-
tricts in the Northern region, malaria has remained a
challenge. A survey conducted in the adjacent district of
Apac in 2001–2002 found perennial holoendemic mal-
aria with parasite prevalence rates of 70-90% in children
less than 10 years of age [38]. In the subsequent 2009
survey conducted in Apac district, age sero-prevalence
curves gave no indication of recent changes in malaria
transmission intensity in the area [39]. This calls for ur-
gent scale up of malaria prevention interventions with
proven bioefficacy to rapidly achieve high coverage and
resulting individual and community protection from
malaria.
Current WHO guidelines recommend combining
ITNs and IRS in various transmission settings, especially
in areas with holoendemic and epidemic malaria [40].
LLINs and IRS could be used together in the same
households in Northern and Eastern regions to suppress
malaria transmission. However, if LLINs are to be com-
bined with IRS for malaria prevention and control, the
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should be done with caution to avoid further exacerbat-
ing existing resistance. Products with the highest proven
bioefficacy against local vector populations should be se-
lected and IRS chemicals should differ from pyrethroids
in their mode of action. In the absence of novel classes
of insecticides, organophosphate- or carbamate-based
IRS could be used where both LLIN and IRS are applied
to form part of an insecticide resistance management
strategy [41]. Encouragingly, recent insecticide suscepti-
bility evaluations in Uganda found high susceptibility to
carbamates and organophosphates in malaria vector
populations (Additional file 2). A parasitemia survey in
children conducted in late 2010 in three contiguous dis-
tricts of Northern Uganda found that parasitemia levels
were lower in two districts that had been sprayed with
carbamates ( 37.0% and 16.7% positive smears) com-
pared to a non-sprayed district ( 49.8% positive smears)
[42]. There is a need for routine resistance surveillance
and ongoing LLIN and IRS bioefficacy assessments
against local vector populations so that products with
significantly reduced efficacy relative to other available
options can be replaced accordingly.
Conclusions
Pyrethroid resistance in malaria vectors in Uganda is
high and is likely to limit the impact of LLINs. Evalu-
ation of the efficacy of various LLINs against An.
gambiae populations from different malaria transmission
zones has provided valuable information on wide varia-
tions depending on the population and LLIN being
tested. Such information can be used to make rational
decisions for selecting LLINs with the highest antici-
pated bioefficacy without waiting for indisputable proof
of control failures from more comprehensive studies.
Monitoring the efficacy of LLINs should be undertaken
regularly in order to guide policy on selection and distri-
bution of LLINs.
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